Viewing Study NCT02660034


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-03-04 @ 1:34 AM
Study NCT ID: NCT02660034
Status: COMPLETED
Last Update Posted: 2021-12-06
First Post: 2016-01-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors
Sponsor: BeiGene
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BGB-A317/BGB-290_Study_001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View